The FDA is approving Perjeta, a drug proven to shrink tumors before surgery in breast cancer patients. CBS News contributor Dr. David Agus joins the "CBS This Morning" co-hosts to discuss the promising drug and what it could mean for cancer patients.
FDA Approves 'Historic' Cancer Drug
The FDA is approving Perjeta, a drug proven to shrink tumors before surgery in breast cancer patients. CBS News contributor Dr. David Agus joins the "CBS This Morning" co-hosts to discuss the promising drug and what it could mean for cancer patients.
Sep 16, 2013
Latest in Operations
Sonair Accelerating Rollout of 3D Ultrasonic Sensor for Robots
September 17, 2025
Nvidia CEO Huang Says He's Disappointed by China Chip Curbs
September 17, 2025